Agile Therapeutics, a biotech developing the first low-dose contraceptive patch, raised $55 million in a downsized IPO by offering 9.2 million shares at $6. The company had originally planned to raise $60 million by offering 4.6 million shares at $12 to $14 but...read more
Agile Therapeutics, a biotech developing the first low-dose contraceptive patch, lowered the proposed deal size for its upcoming IPO on Thursday. The Princeton, NJ-based company now plans to raise $55 million by offering 9.2 million shares at a price of $6. The...read more
Agile Therapeutics, a biotech developing prescription adhesive contraceptives, announced terms for its IPO on Friday. The Princeton, NJ-based company plans to raise $60 million by offering 4.6 million shares at a price range of $12 to $14. At the midpoint of the...read more
Agile Therapeutics prices downsized IPO at $6
Agile Therapeutics, a biotech developing the first low-dose contraceptive patch, raised $55 million in a downsized IPO by offering 9.2 million shares at $6. The company had originally planned to raise $60 million by offering 4.6 million shares at $12 to $14 but...read more
Agile Therapeutics decreases proposed IPO deal size
Agile Therapeutics, a biotech developing the first low-dose contraceptive patch, lowered the proposed deal size for its upcoming IPO on Thursday. The Princeton, NJ-based company now plans to raise $55 million by offering 9.2 million shares at a price of $6. The...read more
8 US IPOs planned for the week of May 19
The following IPOs are expected to price this week: 21st Century Oncology Holdings (ICC), the largest integrated network of cancer care centers and affiliated physicians...read more
Contraceptive patch biotech Agile Therapeutics sets terms for $60 million IPO
Agile Therapeutics, a biotech developing prescription adhesive contraceptives, announced terms for its IPO on Friday. The Princeton, NJ-based company plans to raise $60 million by offering 4.6 million shares at a price range of $12 to $14. At the midpoint of the...read more